StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.80+0.35 (+14.29%)

Close on Nov 18, 2026Market cap $121.23MP/E –Yield –

NRX Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

NRX Pharmaceuticals's total debt was $9.16M at Dec 31, 2023. For fiscal 2023 it was $9.16M, down 13.0% from the year before. The highest annual figure on record is $10.53M in fiscal 2022.

Annual total debt

PeriodPeriod endValueChange
FY2023Dec 31, 2023$9.16M-13.0%
FY2022Dec 31, 2022$10.53M+585.4%
FY2019Dec 31, 2019$1.54M+122.6%
FY2018Dec 31, 2018$690.00K–
FY2017Dec 31, 2017$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$9.16M-13.0%
Q3 FY2023Sep 30, 2023$10.07M+555.7%
Q2 FY2023Jun 30, 2023$12.69M+1739.4%
Q1 FY2023Mar 31, 2023$12.19M–
Q4 FY2022Dec 31, 2022$10.53M–
Q4 FY2019Dec 31, 2019$1.54M–
Q4 FY2018Dec 31, 2018$690.00K–
Q4 FY2017Dec 31, 2017$0–

More NRX Pharmaceuticals figures

See a number that looks wrong?